CERO — CERo Therapeutics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $5.05m
- $6.51m
Annual cashflow statement for CERo Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.316 | -0.668 | -2.54 |
| Non-Cash Items | 0 | -2.84 | -0.492 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.382 | 2.41 | 1.5 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Change in Taxes Payable | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -0.697 | -1.09 | -1.52 |
| Other Investing Cash Flow Items | -179 | 181 | -7.94 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | -179 | 181 | -7.94 |
| Financing Cash Flow Items | 7.91 | — | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 180 | -139 | -32.6 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 1.1 | 41 | -42 |